Shinji Suzuki

This inventor holds 18 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Shionogi Company Limited, Sumitomo Electric Industries, Limited, The Tokyo Electric Power Company, Incorporated. Active years: 1990-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinji Suzuki. Retrieved from https://idiyas.com/inventor/shinji-suzuki-xqaose5t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 2)

% Patents Active = 38.9

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 6.6

ph-index = 7

Forward Citations = 244(Granted Patents)

Location History:

Koka-gun, JP (1999)
Shiga, JP (2001 - 2004)
Osaka, JP (1990 - 2023)

Company Filing History:

14 out of 1,001

Shionogi Company Limited

patents

2 out of 10,652

Sumitomo Electric Industries, Limited

patents

2 out of 177

The Tokyo Electric Power Company, Incorporated

6. 1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 1990-2026

Loading Chart...

Areas of Expertise:

Antiviral Activity

BACE1 Inhibitor

TRPV4 Inhibitor

Alzheimer's Disease

Aminodihydrothiazine

Pyrimidine Derivatives

Pharmaceutical Composition

Agricultural Fungicide

Mobile Communication

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12528790 - Amide derivative having antiviral activity (2026-01-20),

2. 11629154 - Tetrahydropyranooxazine derivatives having selective BACE1 inhibitory activity (2023-04-18),

3. 9708338 - Aromatic heterocyclylamine derivative having TRPV4-inhibiting activity (2017-07-18),

4. 9029358 - Aminodihydrothiazine derivatives (2015-05-12),

5. 8895548 - Pharmaceutical composition for treating alzheimer's disease (2014-11-25),

6. 8884062 - Aminodihydrothiazine derivatives substituted with a cyclic group (2014-11-11),

7. 8815851 - Aminodihydrothiazine derivatives (2014-08-26),

8. 8633188 - Aminodihydrothiazine derivatives (2014-01-21),

9. 8546380 - Aminodihydrothiazine derivatives (2013-10-01),

10. 8541408 - Aminodihydrothiazine derivatives substituted with a cyclic group (2013-09-24),

11. 8173642 - Aminodihydrothiazine derivatives (2012-05-08),

12. 8168630 - Aminodihydrothiazine derivatives substituted with a cyclic group (2012-05-01),

13. 6800630 - Pyrimidine derivatives having antitumor effect (2004-10-05),

14. 6348598 - N-oxyl compounds, process for the preparation thereof, and process for inhibiting the polymerization of vinyl monomers with the same (2002-02-19),

15. 6313150 - &agr;-substituted phenylacetic acid derivative, its production and agricultural fungicide containing it (2001-11-06),

Title: Innovations and Contributions of Inventor Shinji Suzuki

Introduction

Shinji Suzuki is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various health conditions. With a total of 18 patents to his name, his work has garnered attention for its potential therapeutic applications.

Latest Patents

Among his latest patents, Suzuki has developed tetrahydropyranooxazine derivatives that exhibit selective BACE1 inhibitory activity. This invention provides a compound that effectively inhibits amyloid β production, making it useful as a therapeutic or prophylactic agent for diseases associated with amyloid β proteins. Another notable patent involves an aromatic heterocyclylamine derivative that has TRPV4-inhibiting activity. This compound is represented by a specific formula and is designed to offer pharmaceutical benefits.

Career Highlights

Throughout his career, Shinji Suzuki has worked with reputable companies, including Shionogi & Company Limited and Tokyo Electric Power Company. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects in the pharmaceutical sector.

Collaborations

Suzuki has collaborated with notable colleagues, including Kazuo Ueda and Akira Yukimasa. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Shinji Suzuki's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to inspire future developments in therapeutic agents.

Profile summary based on public USPTO records.